<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13D" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>SCHEDULE 13D/A</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <!-- Field: Pseudo-Tag; ID: Name; Data: Wool Kyle Michael -->
          <cik>0001856536</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>


    </filerInfo>
  </headerData>
  <formData>
    <coverPageHeader>
      <amendmentNo>7</amendmentNo>
      <securitiesClassTitle>Common Stock, par value $0.0001 per share</securitiesClassTitle>
      <dateOfEvent>04/16/2025</dateOfEvent>
      <previouslyFiledFlag>false</previouslyFiledFlag>
      <issuerInfo>
        <issuerCIK>0000012239</issuerCIK>
        <issuerCUSIP>008875304</issuerCUSIP>
        <issuerName>Dominari Holdings Inc.</issuerName>
        <address>
          <com:street1>725 FIFTH AVENUE</com:street1>
          <com:street2>22ND FLOOR</com:street2>
          <com:city>New York</com:city>
          <com:stateOrCountry>NY</com:stateOrCountry>
          <com:zipCode>10022</com:zipCode>
        </address>
      </issuerInfo>
      <authorizedPersons>
        <notificationInfo>
          <personName>Robert Charron</personName>
          <personPhoneNum>(212) 370-1300</personPhoneNum>
          <personAddress>
            <com:street1>Ellenoff Grossman &amp; Schole LLP</com:street1>
            <com:street2>1345 6th Avenue</com:street2>
            <com:city>New York</com:city>
            <com:stateOrCountry>NY</com:stateOrCountry>
            <com:zipCode>10105</com:zipCode>
          </personAddress>
        </notificationInfo>
      </authorizedPersons>
    </coverPageHeader>
    <reportingPersons>
      <reportingPersonInfo>
        <reportingPersonCIK>0001856536</reportingPersonCIK>
        <reportingPersonNoCIK>N</reportingPersonNoCIK>
        <reportingPersonName>Kyle Michael Wool</reportingPersonName>
        <fundType>PF</fundType>
        <fundType>OO</fundType>
        <legalProceedings>N</legalProceedings>
        <citizenshipOrOrganization>X1</citizenshipOrOrganization>
        <soleVotingPower>58262.00</soleVotingPower>
        <sharedVotingPower>7355328.00</sharedVotingPower>
        <soleDispositivePower>58262.00</soleDispositivePower>
        <sharedDispositivePower>7355328.00</sharedDispositivePower>
        <aggregateAmountOwned>7413590.00</aggregateAmountOwned>
        <isAggregateExcludeShares>N</isAggregateExcludeShares>
        <percentOfClass>37.74</percentOfClass>
        <typeOfReportingPerson>IN</typeOfReportingPerson>
        <commentContent>(1) Of the 7,355,328 shares reported as beneficially owned with shared voting and dispositive power, 6,113,339 shares are beneficially owned directly by Mr. Wool, including 5,000,000 shares underlying a stock option of the Issuer's Common Stock, which is exercisable within 60 days of April 16, 2025 and directly owned by the Reporting Person, and 1,241,989 shares are beneficially owned directly by Ms. Yu, Mr. Wool's spouse. Of the 58,262 shares reported as beneficially owned with sole voting and dispositive power, 27,750 shares are held by Mr. Wool's SEP-IRA, over which Mr. Wool has sole control, 24,000 shares are held by Mr. Wool's Rollover IRA, over which Mr. Wool has sole control, 1,477 shares are held by Catatonk Creek, LLC, of which Mr. Wool is the sole member, 1,476 shares are held by Tioga 22, LLC, of which Mr. Wool is the sole member, and 3,559 shares are held in a UTMA account for the benefit of a minor relative. This excludes an aggregate of 576,368 shares issuable pursuant to Warrants (as defined below) purchased by the Reporting Person in connection with the Issuer's private placement and registered direct offering (collectively, the "Offering") that closed on February 12, 2025, which are not currently exercisable due to certain beneficial ownership blockers. (2) Row 13 is calculated based on an aggregate of 19,643,897 shares of Common Stock which includes 14,643,897 shares of Common Stock of the Issuer outstanding as of April 16, 2025 and an aggregate of 5,000,000 shares of Common Stock issuable upon exercise of the stock option accepted by Mr. Wool from the Issuer's Compensation Committee under the Issuer's 2022 Equity Incentive Plan on April 16, 2025.</commentContent>
      </reportingPersonInfo>
      <reportingPersonInfo>
        <reportingPersonCIK>0001933417</reportingPersonCIK>
        <reportingPersonNoCIK>N</reportingPersonNoCIK>
        <reportingPersonName>Soo Yu</reportingPersonName>
        <fundType>PF</fundType>
        <fundType>OO</fundType>
        <legalProceedings>N</legalProceedings>
        <citizenshipOrOrganization>X1</citizenshipOrOrganization>
        <soleVotingPower>15227.00</soleVotingPower>
        <sharedVotingPower>7355328.00</sharedVotingPower>
        <soleDispositivePower>15227.00</soleDispositivePower>
        <sharedDispositivePower>7355328.00</sharedDispositivePower>
        <aggregateAmountOwned>7370555.00</aggregateAmountOwned>
        <isAggregateExcludeShares>N</isAggregateExcludeShares>
        <percentOfClass>37.52</percentOfClass>
        <typeOfReportingPerson>IN</typeOfReportingPerson>
        <commentContent>(1) Of the 7,355,328 shares reported as beneficially owned with shared voting and dispositive power, 1,241,989 shares are beneficially owned directly by Ms. Yu, 6,113,339 shares are beneficially owned directly by Mr. Wool, Ms. Yu's spouse, including 5,000,000 shares underlying a stock option of the Issuer's Common Stock, which is exercisable within 60 days of April 16, 2025 and directly owned by the Reporting Person. Of the 15,227 reported as beneficially owned with sole voting and dispositive power, 13,750 shares are held by Ms. Yu's Pension and 1,477 shares are held by Dongam, LLC, of which Ms. Yu is the sole member. (2) Row 13 is calculated based on an aggregate of 19,643,897 shares of Common Stock which includes 14,643,897 shares of Common Stock of the Issuer outstanding as of April 16, 2025 and an aggregate of 5,000,000 shares of Common Stock issuable upon exercise of the stock option accepted by Mr. Wool from the Issuer's Compensation Committee under the Issuer's 2022 Equity Incentive Plan on April 16, 2025.</commentContent>
      </reportingPersonInfo>
    </reportingPersons>
    <items1To7>
      <item1>
        <securityTitle>Common Stock, par value $0.0001 per share</securityTitle>
        <issuerName>Dominari Holdings Inc.</issuerName>
        <issuerPrincipalAddress>
          <com:street1>725 FIFTH AVENUE</com:street1>
          <com:street2>22ND FLOOR</com:street2>
          <com:city>New York</com:city>
          <com:stateOrCountry>NY</com:stateOrCountry>
          <com:zipCode>10022</com:zipCode>
        </issuerPrincipalAddress>
        <commentText>EXPLANATORY NOTE This Amendment No. 7 to Schedule 13D (this "Amendment No. 7") is filed to amend the Schedule 13D (the "Initial Schedule 13D") filed with the Securities and Exchange Commission on December 28, 2022 by Kyle Michael Wool and Soo Yu, as amended by Amendment No. 1 to Schedule 13D filed on July 6, 2023 ("Amendment No. 1"), as amended by Amendment No. 2 to Schedule 13D filed on December 28, 2023 ("Amendment No. 2"), as amended by Amendment No. 3 to Schedule 13D filed on December 28, 2023 ("Amendment No. 3"), as amended by Amendment No. 4 to Schedule 13D filed on January 3, 2025 ("Amendment No. 4"), as amended by Amendment No. 5 to Schedule 13D filed on February 12, 2025, as amended by Amendment No. 6 to Schedule 13D filed on March 25, 2025, ("Amendment No. 6", and collectively with the Initial Schedule 13D, Amendment No. 1, Amendment No. 2, Amendment No. 3, Amendment No. 4, Amendment No. 5, the "Schedule 13D"). This Amendment No. 7 supplements and amends the Schedule 13D as specifically set forth herein. Except as amended and supplemented by this Amendment No. 7, the Schedule 13D remains unchanged.</commentText>
      </item1>
      <item2>
        <filingPersonName>Paragraphs (a) and (c) of Item 2 of the Original Schedule 13D are hereby deleted in their entirety and replaced with the following: This statement on Schedule 13D is being filed jointly by Kyle Michael Wool and Soo Yu as individuals, each of whom is referred to herein, together, as the "Reporting Persons." The Reporting Persons are husband and wife.</filingPersonName>
        <principalBusinessAddress>The principal business address of the Reporting Persons is c/o Dominari Holdings Inc., 725 5th Avenue, 22nd Floor, New York, New York 10022.</principalBusinessAddress>
        <principalJob>Mr. Wool is President of the Issuer, Chief Executive Officer of Dominari Financial Inc. (the Issuer's financial services subsidiary) and Chief Executive Officer of Dominari Securities LLC (the Issuer's broker-dealer subsidiary) ("Dominari Securities"). Each of Mr. Wool and Ms. Yu also serve as directors on the board of directors of the Issuer. On April 3, 2023, Ms. Yu entered into an Employment Agreement with Dominari Securities, as amended by the Amendment to Employment Agreement, dated as of April 19, 2023 (the "Employment Agreement"), to serve, initially, as a special projects manager and a registered brokerage representative of Dominari Securities, and she was subsequently promoted to Chief Operating Officer of Dominari Securities.</principalJob>
      </item2>
      <item3>
        <fundsSource>Item 3 of the Schedule 13D is hereby amended and supplemented with the following: On April 16, 2025, the Reporting Person accepted a stock option to purchase 5,000,000 shares of the Issuer's Common Stock from the Compensation Committee of the Issuer's Board under the Issuer's 2022 Equity Incentive Plan. The acceptance of the stock option to purchase 5,000,000 shares of the Issuer's Common Stock by the Reporting Person is described in Reports of the Issuer on Forms 8-K, 10-Q or 10-K, as applicable, and the Reporting Person's filings pursuant to Section 16 of the Securities Exchange Act of 1934, as amended.</fundsSource>
      </item3>
      <item4>
        <transactionPurpose>Item 4 of the Schedule 13D is hereby amended and supplemented with the following: The transaction giving rise to the filing of this Amendment No. 6 is the acceptance of the stock option to purchase 5,000,000 shares of the Issuer's Common Stock by the Reporting Person from the Compensation Committee of the Issuer's Board under the Issuer's 2022 Equity Incentive Plan. Except as disclosed in this Item 4, the Reporting Person has no current plan or proposal which relate to or would result in any of the events described in Items (a) through (j) of the instructions to Item 4 of Schedule 13D. The Reporting Person may, at any time and from time to time, review or reconsider his position and/or change his purpose.</transactionPurpose>
      </item4>
      <item5>
        <percentageOfClassSecurities>(a)-(b) The Reporting Persons have shared voting and dispositive power over 7,355,328 shares of Common Stock of the Issuer as a result of their status as husband and wife. Of the 7,355,328 shares of Common Stock that the Reporting Persons have shared voting and dispositive power over, 6,113,339 shares are beneficially owned directly by Mr. Wool, including 5,000,000 shares underlying a stock option of Common Stock issuable upon exercise of the stock option accepted by the Reporting Person, and 1,241,989 shares are beneficially owned directly by Ms. Yu. In addition, Mr. Wool has sole voting and dispositive power over 58,262 shares of Common Stock, which he holds indirectly as follows: 27,500 shares are held by Mr. Wool's SEP-IRA, over which Mr. Wool has sole control, 24,000 shares are held by Mr. Wool's Rollover IRA, over which Mr. Wool has sole control, 1,477 shares are held by Catatonk Creek, LLC, of which Mr. Wool is the sole member; 1,476 shares are held by Tioga 22, LLC, of which Mr. Wool is the sole member; and 3,559 shares are held in a UTMA account for the benefit of a minor relative. Ms. Yu has sole voting and dispositive power over an additional 15,227, which she holds indirectly as follows: 13,750 shares are held by Ms. Yu's Pension and 1,477 shares, which are held by Dongam, LLC, of which Ms. Yu is the sole member. Accordingly, on an individual basis, Mr. Wool and Ms. Yu beneficially own 37.74% and 37.52%, respectively, of the outstanding Common Stock of the Issuer based on an aggregate of 19,643,897 shares of Common Stock which includes 14,643,897 shares of Common Stock of the Issuer outstanding as of April 16, 2025 and an aggregate of 5,000,000 shares of Common Stock issuable upon exercise of the stock option accepted by Mr. Wool from the Issuer's Compensation Committee under the Issuer's 2022 Equity Incentive Plan on April 16, 2025.</percentageOfClassSecurities>
        <numberOfShares>(a)-(b) The Reporting Persons have shared voting and dispositive power over 2,355,328 shares of Common Stock of the Issuer as a result of their status as husband and wife. Of the 2,355,328 shares of Common Stock that the Reporting Persons have shared voting and dispositive power over, 6,113,339 shares are beneficially owned directly by Mr. Wool, including 5,000,000 shares underlying a stock option of Common Stock issuable upon exercise of the stock option accepted by the Reporting Person, and 1,241,989 shares are beneficially owned directly by Ms. Yu. In addition, Mr. Wool has sole voting and dispositive power over 58,262 shares of Common Stock, which he holds indirectly as follows: 27,500 shares are held by Mr. Wool's SEP-IRA, over which Mr. Wool has sole control, 24,000 shares are held by Mr. Wool's Rollover IRA, over which Mr. Wool has sole control, 1,477 shares are held by Catatonk Creek, LLC, of which Mr. Wool is the sole member; 1,476 shares are held by Tioga 22, LLC, of which Mr. Wool is the sole member; and 3,559 shares are held in a UTMA account for the benefit of a minor relative. Ms. Yu has sole voting and dispositive power over an additional 15,227, which she holds indirectly as follows: 13,750 shares are held by Ms. Yu's Pension and 1,477 shares, which are held by Dongam, LLC, of which Ms. Yu is the sole member. Accordingly, on an individual basis, Mr. Wool and Ms. Yu beneficially own 37.74% and 37.52%, respectively, of the outstanding Common Stock of the Issuer based on 19,643,897 shares of Common Stock which includes 14,643,897 shares of Common Stock of the Issuer outstanding as of April 16, 2025 and an aggregate of 5,000,000 shares of Common Stock issuable upon exercise of the stock option accepted by Mr. Wool from the Issuer's Compensation Committee under the Issuer's 2022 Equity Incentive Plan on April 16, 2025.</numberOfShares>
        <transactionDesc>The following transactions in the shares of Common Stock were conducted by the Reporting Person within the past sixty (60) days: (1) The Reporting Person acquired 288,814 shares of Common Stock, Series A Warrants to purchase up to 288,814 shares of Common Stock and Series B Warrants to purchase up to 288,814 shares of Common Stock of the Issuer at a combined purchase price of $3.47 per share and accompanying Warrants with personal funds pursuant to the Offering for his personal account; (2) The Reporting Person was issued 154,559 shares of the Issuer's Common Stock as issued by the Compensation Committee of the Issuer's Board on March 24, 2025 and (3) The Reporting Person was issued 154,559 shares of the Issuer's Common Stock as issued by the Compensation Committee of the Issuer's Board on March 24, 2025; (4) The Reporting Person accepted a stock option to purchase 5,000,000 shares of the Issuer's Common Stock from the Compensation Committee of the Issuer's Board under the Issuer's 2022 Equity Incentive Plan on April 16, 2025.</transactionDesc>
        <listOfShareholders>None.</listOfShareholders>
        <date5PercentOwnership>Not applicable.</date5PercentOwnership>
      </item5>
      <item6>
        <contractDescription>In his capacity as President of the Issuer, the Reporting Person may be entitled to receive cash compensation and equity compensation, including share options or other equity awards, pursuant to the Issuer's 2022 Equity Incentive Plan. Such compensation is based on the Issuer meeting or exceeding certain annual revenue amounts during specified calendar years. The information provided or incorporated by reference in Items 2, 3, 4 and 5 of this Amendment No. 7, is hereby incorporated herein by this reference thereto.</contractDescription>
      </item6>
      <item7>
        <filedExhibits>Exhibit 1.01 Joint Filing Agreement, dated as of April 16, 2025, between the Reporting Persons.</filedExhibits>
      </item7>
    </items1To7>
    <signatureInfo>
      <signaturePerson>
        <signatureReportingPerson>Kyle Michael Wool</signatureReportingPerson>
        <signatureDetails>
          <signature>/s/ Kyle Wool</signature>
          <title>Kyle Wool</title>
          <date>04/16/2025</date>
        </signatureDetails>
      </signaturePerson>
      <signaturePerson>
        <signatureReportingPerson>Soo Yu</signatureReportingPerson>
        <signatureDetails>
          <signature>/s/ Soo Yu</signature>
          <title>Soo Yu</title>
          <date>04/16/2025</date>
        </signatureDetails>
      </signaturePerson>
    </signatureInfo>
  </formData>

</edgarSubmission>
